Jason Zemansky
Stock Analyst at B of A Securities
(4.84)
# 80
Out of 4,876 analysts
40
Total ratings
75%
Success rate
35.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $94 → $109 | $101.74 | +7.14% | 10 | Jun 11, 2025 | |
| KROS Keros Therapeutics | Downgrades: Neutral | $32 → $18 | $13.51 | +33.23% | 2 | Jun 10, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $32 → $9 | $2.59 | +247.49% | 1 | May 28, 2025 | |
| CYTK Cytokinetics | Maintains: Neutral | $62 → $54 | $33.91 | +59.25% | 4 | Apr 15, 2025 | |
| TVTX Travere Therapeutics | Maintains: Buy | $29 → $31 | $15.13 | +104.89% | 4 | Apr 1, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $22 → $17 | $8.50 | +100.00% | 5 | Feb 19, 2025 | |
| KURA Kura Oncology | Maintains: Buy | $36 → $29 | $5.73 | +406.11% | 2 | Nov 22, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $30 → $31 | $9.29 | +233.69% | 3 | Aug 15, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $1.02 | +145.10% | 5 | Jun 20, 2024 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $1.14 | +777.19% | 4 | May 12, 2023 |
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $94 → $109
Current: $101.74
Upside: +7.14%
Keros Therapeutics
Jun 10, 2025
Downgrades: Neutral
Price Target: $32 → $18
Current: $13.51
Upside: +33.23%
Rocket Pharmaceuticals
May 28, 2025
Maintains: Buy
Price Target: $32 → $9
Current: $2.59
Upside: +247.49%
Cytokinetics
Apr 15, 2025
Maintains: Neutral
Price Target: $62 → $54
Current: $33.91
Upside: +59.25%
Travere Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $15.13
Upside: +104.89%
Arcus Biosciences
Feb 19, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $8.50
Upside: +100.00%
Kura Oncology
Nov 22, 2024
Maintains: Buy
Price Target: $36 → $29
Current: $5.73
Upside: +406.11%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $9.29
Upside: +233.69%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $1.02
Upside: +145.10%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.14
Upside: +777.19%